FUJIFILM Diosynth Biotechnologies broke ground Thursday on a $2 billion facility that will be the largest end-to-end biopharmaceutical manufacturing facility in North America, bolstering Holly Springs' reputation as a leading location for life sciences.
The Town Council and Town staff joined company officials and other state and local officials for the groundbreaking in Oakview Innovation Park off New Hill Road.
The facility is scheduled to open in 2025 and provide more than 700 high-quality jobs by the end of 2028. The facility will employ engineers, scientists, manufacturing personnel, and others in supporting roles. The company says sustainability will be at the core of the facility, targeting 100 percent clean energy, cutting edge waste disposal, and recycling.
Following a competitive review, FUJIFILM Diosynth Biotechnologies chose Holly Springs because of its strong pool of technical talent, local resources and partners with the right competencies, clean energy resources, and sustainability for future growth.
The company said the state-of-the-art facility in the "vibrant North Carolina biotech hub of Holly Springs" will enable it to accelerate the development and supply of life-impacting medicines to patients.
In March, Gov. Roy Cooper announced the selection of Holly Springs for the facility during a ceremony at Holly Springs Cultural Center.